• Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use

    3 days ago - By Healio

    Ixekizumab is efficacious in patients with psoriatic arthritis for up to 1 year, with or without concomitant methotrexate use, according to data published in Arthritis Research & Therapy.
    “Ixekizumab has been demonstrated to improve the signs and symptoms of PsA in patients who were biologic-naive or had previous inadequate response or intolerance with TNF inhibitors ,” Bernard Combe, MD, PhD, of CHU Montpellier, at Montpellier University, in France, and colleagues wrote. “The efficacy and safety data of IXE with and without MTX up to week 24 from
    Read more ...